The launched technology Apollo ESG System is authorised by both US FDA and CDSCO while, Orbera365 System is indicated by ...

The scale rates three sections of the colon, right (cecum and ascending colon), mid-colon (transverse and descending) and rectosigmoid, on a five-point scale (0–4). Total score (0–14) is ...

Let's face it: It's no fun walking around feeling more puffed up than a balloon in the Macy's Thanksgiving Day Parade. That's why we went to some of the world's leading GI docs for advice. Read on to ...

Lucid Diagnostics (LUCD) and subsidiary of PAVmed (PAVM), announced that the manuscript for its CLinical Utility of EsoGuard, or CLUE, study ...

Crohn’s disease (CD) is a chronic idiopathic inflammatory bowel disease, with a complex aetiology involving genetic, ...

True You Weight Loss, the nation's first dedicated endobariatric weight loss center, today announced two new FDA-authorized clinical trials aimed at providing innovative, non-surgical solutions for ...

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that ...

The global medical equipment maintenance market size is estimated to grow by USD 51.2 billion from 2024 to 2028, according to ...

The intragastric balloons market has gained traction as a non-surgical solution for managing obesity, one of the leading health concerns globally. These balloons, temporarily placed in the stomach to ...